114 related articles for article (PubMed ID: 7540143)
1. Structural requirements for neuropeptide Y in mast cell and G protein activation.
Mousli M; Trifilieff A; Pelton JT; Gies JP; Landry Y
Eur J Pharmacol; 1995 Mar; 289(1):125-33. PubMed ID: 7540143
[TBL] [Abstract][Full Text] [Related]
2. Role of positive charges of neuropeptide Y fragments in mast cell activation.
Mousli M; Landry Y
Agents Actions; 1994 Jun; 41 Spec No():C41-2. PubMed ID: 7526655
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins?
Grundemar L; Krstenansky JL; Håkanson R
Eur J Pharmacol; 1994 Jun; 258(1-2):163-6. PubMed ID: 7523149
[TBL] [Abstract][Full Text] [Related]
4. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.
Emadi-Khiav B; Mousli M; Bronner C; Landry Y
Eur J Pharmacol; 1995 Jan; 272(1):97-102. PubMed ID: 7536161
[TBL] [Abstract][Full Text] [Related]
5. Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.
Cross LJ; Beck-Sickinger AG; Bienert M; Gaida W; Jung G; Krause E; Ennis M
Br J Pharmacol; 1996 Jan; 117(2):325-32. PubMed ID: 8789386
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
Grundemar L; Håkanson R
Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
[TBL] [Abstract][Full Text] [Related]
7. C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.
Shen GH; Grundemar L; Zukowska-Grojec Z; Håkanson R; Wahlestedt C
Eur J Pharmacol; 1991 Nov; 204(3):249-56. PubMed ID: 1723049
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y-induced mast cell activation.
Cross LJ; Beck-Sickinger AG; Beyerman M; Krause E; Bienert M; Ennis M
Biochem Soc Trans; 1994 Feb; 22(1):7S. PubMed ID: 7515834
[No Abstract] [Full Text] [Related]
9. Influence of alpha-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation.
Cross LJ; Ennis M; Krause E; Dathe M; Lorenz D; Krause G; Beyermann M; Bienert M
Eur J Pharmacol; 1995 Nov; 291(3):291-300. PubMed ID: 8719413
[TBL] [Abstract][Full Text] [Related]
10. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
Mousli M; Hugli TE; Landry Y; Bronner C
J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
[TBL] [Abstract][Full Text] [Related]
11. Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.
Emadi-Khiav B; Mousli M; Landry Y
Inflamm Res; 1995 Apr; 44 Suppl 1():S26-7. PubMed ID: 8520984
[No Abstract] [Full Text] [Related]
12. A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin.
Bueb JL; Mousli M; Landry Y; Bronner C
Agents Actions; 1990 Apr; 30(1-2):98-101. PubMed ID: 1695472
[TBL] [Abstract][Full Text] [Related]
13. Activation of exocytosis by the heterotrimeric G protein Gi3.
Aridor M; Rajmilevich G; Beaven MA; Sagi-Eisenberg R
Science; 1993 Dec; 262(5139):1569-72. PubMed ID: 7504324
[TBL] [Abstract][Full Text] [Related]
14. The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins.
Chahdi A; Daeffler L; Bueb JL; Gies JP; Landry Y
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):357-62. PubMed ID: 9606019
[TBL] [Abstract][Full Text] [Related]
15. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
Mousli M; Hugli TE; Landry Y; Bronner C
Immunopharmacology; 1994; 27(1):1-11. PubMed ID: 7515863
[TBL] [Abstract][Full Text] [Related]
16. Midkine induces histamine release from mast cells and the immediate cutaneous response.
Hiramatsu K; Yoshida H; Kimura T; Takagi K
Biochem Mol Biol Int; 1998 Mar; 44(3):453-62. PubMed ID: 9556205
[TBL] [Abstract][Full Text] [Related]
17. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin and proadrenomedullin N-terminal 20 peptide induce histamine release from rat peritoneal mast cell.
Yoshida M; Yoshida H; Kitaichi K; Hiramatsu K; Kimura T; Ito Y; Kume H; Yamaki K; Suzuki R; Shibata E; Hasegawa T; Takagi K
Regul Pept; 2001 Sep; 101(1-3):163-8. PubMed ID: 11495692
[TBL] [Abstract][Full Text] [Related]
19. Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface.
Chahdi A; Mousli M; Landry Y
Eur J Pharmacol; 1998 Jan; 341(2-3):329-35. PubMed ID: 9543256
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of basic secretagogue-induced signaling in mast cells by cell permeable G alpha i-derived peptides.
Shefler I; Zavaro O; Raz T; Baram D; Sagi-Eisenberg R
Int Arch Allergy Immunol; 2008; 145(2):131-40. PubMed ID: 17848806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
